To establish a treatment for GI symptoms of cystic fibrosis, it is necessary to develop a symptom evaluation tool

[1]  K. Whelan,et al.  A high prevalence of chronic gastrointestinal symptoms in adults with cystic fibrosis is detected using tools already validated in other GI disorders , 2019, United European gastroenterology journal.

[2]  M. Currie,et al.  High‐dose linaclotide is effective and safe in patients with chronic constipation: A phase III randomized, double‐blind, placebo‐controlled study with a long‐term open‐label extension study in Japan , 2018, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[3]  P. Jaksch,et al.  Impact of nutritional status on pulmonary function after lung transplantation for cystic fibrosis , 2018, United European gastroenterology journal.

[4]  S. Fukudo,et al.  Randomized, double‐blind, placebo‐controlled study vs data in the daily practice using linaclotide in patients with irritable bowel syndrome with constipation , 2018, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[5]  M. Boermeester,et al.  United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU) , 2017, United European gastroenterology journal.

[6]  D. Drossman,et al.  Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction. , 2016, Gastroenterology.

[7]  R. Spiller,et al.  Bowel Disorders. , 2016, Gastroenterology.

[8]  T. Hibi,et al.  Efficacy of Solifenacin on Irritable Bowel Syndrome With Diarrhea: Open-label Prospective Pilot Trial , 2012, Journal of neurogastroenterology and motility.

[9]  T. Hibi,et al.  Classification of functional dyspepsia based on concomitant bowel symptoms , 2012, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.